Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Leventakos

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 15, 2016
Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and AtezolizumabKonstantinos Leventakos, Aaron S Mansfield
JCO Oncology Practice|February 3, 2025
Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung CancerAntonious Ziad Hazim, Konstantinos Leventakos, Vinicius Ernani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Fungal infections in leukemia patients: how do we prevent and treat them?Konstantinos Leventakos, Russell E Lewis, Dimitrios P Kontoyiannis
Cancers|February 13, 2025
Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)Syeda A Mina, Mohamed Shanshal, Konstantinos Leventakos, et al.
Journal of Thoracic Disease|December 7, 2020
Changing paradigm in advanced and metastatic non-small cell lung cancerDipesh Uprety, Kaushal Parikh, Anita Sawkar, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisRussell E Lewis, Konstantinos Leventakos, Guangling Liao, et al.
Current Treatment Options in Oncology|August 31, 2020
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic TreatmentsDipesh Uprety, Thorvardur R Halfdanarson, Julian R Molina, et al.
Journal of Thoracic Disease|December 7, 2020
Radiation and immunotherapy: emerging mechanisms of synergyWilliam G Breen, Konstantinos Leventakos, Haidong Dong, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
The Faces of Financial Toxicity: A Qualitative Interview Study of Financial Toxicity in Advanced Cancer Patients in Phase I Oncology TrialsColt Williams, Leigh Meyer, Omar Kawam, et al.
Blood|October 22, 2009
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolitesRonen Ben-Ami, Russell E Lewis, Konstantinos Leventakos, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 15, 2016
Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and AtezolizumabKonstantinos Leventakos, Aaron S Mansfield
JCO Oncology Practice|February 3, 2025
Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung CancerAntonious Ziad Hazim, Konstantinos Leventakos, Vinicius Ernani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Fungal infections in leukemia patients: how do we prevent and treat them?Konstantinos Leventakos, Russell E Lewis, Dimitrios P Kontoyiannis
Cancers|February 13, 2025
Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)Syeda A Mina, Mohamed Shanshal, Konstantinos Leventakos, et al.
Journal of Thoracic Disease|December 7, 2020
Changing paradigm in advanced and metastatic non-small cell lung cancerDipesh Uprety, Kaushal Parikh, Anita Sawkar, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisRussell E Lewis, Konstantinos Leventakos, Guangling Liao, et al.
Current Treatment Options in Oncology|August 31, 2020
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic TreatmentsDipesh Uprety, Thorvardur R Halfdanarson, Julian R Molina, et al.
Journal of Thoracic Disease|December 7, 2020
Radiation and immunotherapy: emerging mechanisms of synergyWilliam G Breen, Konstantinos Leventakos, Haidong Dong, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
The Faces of Financial Toxicity: A Qualitative Interview Study of Financial Toxicity in Advanced Cancer Patients in Phase I Oncology TrialsColt Williams, Leigh Meyer, Omar Kawam, et al.
Blood|October 22, 2009
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolitesRonen Ben-Ami, Russell E Lewis, Konstantinos Leventakos, et al.
Pageof 7